Charles River Laboratories | CRL - Trade Debtors

Stock Price
189.80
Daily Change
6.10 3.32%
Monthly
-12.44%
Yearly
15.88%
Q1 Forecast
204.00

Charles River Laboratories reported $1.48B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Agilent USD 1.49B 105M Sep/2025
Align Technology USD 1.1B 2.38M Dec/2025
Bio-Rad Laboratories USD 469.9M 45.2M Jun/2025
Bruker USD 550.9M 28.3M Sep/2025
Cardinal Health USD 13.66B 108M Dec/2025
Charles River Laboratories USD 1.48B 715.2M Sep/2025
Cigna USD 31.71B 3.74B Sep/2025
CVS Health USD 43.86B 3.21B Sep/2025
Danaher USD 3.91B 762M Dec/2025
Dentsply International USD 654M 8M Sep/2025
Elevance Health USD 21.54B 807M Dec/2025
Galapagos EUR 77.67M 145.85M Sep/2025
Hologic USD 584.2M 16.6M Dec/2025
Humana USD 2.68B 1.82B Sep/2025
Illumina USD 854M 125M Dec/2025
Incyte USD 895.89M 53M Sep/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Laboratory Of America USD 2.27B 11.5M Sep/2025
Lonza CHF 1.78B 55M Dec/2025
McKesson USD 28.21B 73M Dec/2025
Merck EUR 4.73B 182M Sep/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Quest Diagnostics USD 1.46B 37M Sep/2025
Revvity USD 680.26M 19.12M Sep/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
UnitedHealth USD 23.02B 346M Dec/2025
Waters USD 748.52M 18.44M Sep/2025
West Pharmaceutical Services USD 625M 42.6M Sep/2025